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Abstract 
Effects of anti-fungal agents on Neurospora growth 
This research note is available in Fungal Genetics Reports: https://newprairiepress.org/fgr/vol22/iss1/4 
Al-Soqur,  A .  E f f e c t s  o f  anti-fungal Conidio,  > IO x 106,  o f  t h e  colonial  temperature-renritiv  strain  c o t - l  (ClOZt)  a were
ogentr  on g rowth  o f  Neurorpora. odded  t o  1 0 0  m l  flasks  conta in ing 30  ml  of  l iquid  Vogel ’s  medium ru$&“ted  wiih one
of  c1  variety  o f  anti-fungol  drugs.  T h e r e  cultures,  t o g e t h e r  w i t h  c o n t r o l  cultures  containing
no anti-fungal  a g e n t ,  w e r e  i n c u b a t e d  a t  250  C,  initially  in o rotary  rhoker  f o r  3 0  hours  a nd
rubrequently  01  static  cultures  fo r  up  to  n ine  doyr.  Mycelia  were  h a r v e s t e d  ot  3 0  h o u r s  and  ot  9  d a y s ,  d r i e d  a+  60°  C  and weighed.
Results  a r e  s h o w ”  01  per  cen t  inh ib i t ion  o f  d ry  we igh t  caused  b y  t h e  d r u g s ,  os  compared  w i th  the  we igh ts  obtained  f r o m  t h e  control
c~ltum.  - - - D e p a r t m e n t  o f  G e n e t i c s , U n i v e r s i t y  o f  A b e r d e e n ,  Scotland.
TABLE
P e r  cent  inhibi t ion Drug
Compound ot 30 hours concentration
Acridine  O r a n g e 100 5
Actinomycin  D 73 5
Bocitrocin 5 5 5 0 0
Borbi  tone 0 5 0 0
Basic  Fuchsin 100 10
Benzolkonium  ch lo r ide 100 0 . 5
C a f f e i n e 9 7 2 mg/ml
Cetylpyridinium  ch lo r ide 100 0 . 5
Cetyltrimethyl  ammonium bromide 100 0 . 5
Chloramphenicol __ __
Chloral  hydrate __ _ _
Chloroquine 5 6 5 0 0
C r y s t a l  v i o l e t 100 I O
C~ClOS~~i”~ 9 5 100
Dequalinium  ch lo r ide 100 0 . 5
Dimethyl  rulphote 100 5 0 0
EDTA __ __
Emetine 0 5 0 0
Erythromyci” 0 I mg/ml
Ethidium  bromide 100 4 5
B - E t h o x y  c a f f e i n e __ __
Gentomyci” 3 6 5 0 0
Gramic id i”  J 100 0 . 5
8-Hydroxyquinoline 100 0 . 5
4-Hydroxyquinoline 8 6 5 0 0
Hydroxyurea 4 0 5 0 0
lodoacetate 9 1 5 0 0
Molochite  g r e e n 100 5
Mepocrine  sulphate 100 0 . 5
Neomyc in  rulphote 3 5 5 0 0
Nyrtoti” 100 0 . 5
Polymyxi”  B iulphote 100 25
Po lypropy lene  glycol  4 2 5 0 5 0 0
P r o p y l e n e  glycol 7 0 3 %
Quinocrine  H C I 9 2 5 0 0
Ri fampic i” 0 I mg/ml
Sodium Azide 100 0 . 5
Trit0” 0 5 0 0
Trypo”  b l u e 14 500
Tyrocidine  H C  I __ _”
Unlerr  o t h e r w i s e  rtoted  (II I  concentrations  o r e  i n  microgromr  per  ml .
Per  cent  inh ib i t ion Drug
a t  9  doyr concent~otion
100 2 5
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